Literature DB >> 6643436

Thermodynamic studies of the protein-protein interactions between cytochrome P-450 and cytochrome b5. Evidence for a central role of the cytochrome P-450 spin state in the coupling of substrate and cytochrome b5 binding to the terminal hemoprotein.

P P Tamburini, G G Gibson.   

Abstract

The interactions between purified rat hepatic microsomal cytochrome P-450 and the type I ligands benzphetamine and cytochrome b5 have been studied in the presence of phospholipid using difference spectrophotometry. Cytochrome b5 was shown to interact with cytochrome P-450 to form a tight 1:1 complex (Kd = 275 nM), in which the proportion of high spin cytochrome P-450 was increased from 7 to 30%. The presence of saturating cytochrome b5 was shown to cause a decrease in the apparent Kd for benzphetamine binding from 111 microM to 40 microM. Likewise, the presence of benzphetamine was shown to cause a decrease in the apparent dissociation constant for cytochrome b5 binding to cytochrome P-450 (Kd = 90 nM). The above interactions were resolved into the basic equilibria inter-relating the various ligation states of the hemoprotein in an energetically closed eight-state free energy coupling model and the relative magnitudes of the microequilibria were analyzed to determine the degree of coupling of the interactions between cytochrome P-450 and both benzphetamine and cytochrome b5. Consequently, the spin state changes in cytochrome P-450 induced by benzphetamine and cytochrome b5 binding were shown to arise because these ligands interact 7 and 4 times more tightly with high spin cytochrome P-450, respectively. Furthermore, the data revealed that these ligands interact at independent sites on cytochrome P-450. Thus the effects of cytochrome b5 upon benzphetamine binding and vice versa were rationalized simply in terms of an increase in the proportion of a high spin (high affinity) conformation of cytochrome P-450 brought about by pre-equilibration with the effector ligand, with the intrinsic binding affinities of the two ligands for the low or high spin states remaining relatively unaltered. The thermodynamic parameters associated with the interactions between cytochrome P-450 and cytochrome b5, determined from the temperature dependence of these interactions, revealed that these protein interactions are entropy driven and probably occur by a hydrophobic mechanism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643436

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

Review 1.  Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?

Authors:  Dmitri R Davydov; James R Halpert
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-12       Impact factor: 4.481

2.  A model of the membrane-bound cytochrome b5-cytochrome P450 complex from NMR and mutagenesis data.

Authors:  Shivani Ahuja; Nicole Jahr; Sang-Choul Im; Subramanian Vivekanandan; Nataliya Popovych; Stéphanie V Le Clair; Rui Huang; Ronald Soong; Jiadi Xu; Kazutoshi Yamamoto; Ravi P Nanga; Angela Bridges; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2013-05-24       Impact factor: 5.157

3.  Thermodynamic studies of substrate binding and spin transitions in human cytochrome P-450 3A4 expressed in yeast microsomes.

Authors:  J P Renaud; D R Davydov; K P Heirwegh; D Mansuy; G H Hui Bon Hoa
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Purification to homogeneity and enzymological characterization of a functional covalent complex composed of cytochromes P-450 isozyme 2 and b5 from rabbit liver.

Authors:  P P Tamburini; J B Schenkman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  P450 reductase and cytochrome b5 interactions with cytochrome P450: effects on house fly CYP6A1 catalysis.

Authors:  Marat B Murataliev; Victor M Guzov; F Ann Walker; René Feyereisen
Journal:  Insect Biochem Mol Biol       Date:  2008-09-27       Impact factor: 4.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.